COMMUNIQUÉS West-GlobeNewswire

-
Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery
11/06/2024 -
Acentra Health Named ‘Corporate Growth Company of the Year’ by ACG National Capital
11/06/2024 -
AI Brain Health Leader Omniscient Closes Series C Funding Round
11/06/2024 -
Racial Disparities in HIV Testing Require Explanation, according to Journal of American Physicians and Surgeons
11/06/2024 -
Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy with an Aim to Expedite BLA Pathway
11/06/2024 -
Outlook Therapeutics® to Present at the Virtual Investor Pitch Conference
11/06/2024 -
Notice to attend the Extra General Meeting of Olink Holding AB (publ)
11/06/2024 -
Scilex Holding Company Announces That Many National Pharmacy Chains and Independent Pharmacies Have Begun Stocking GLOPERBA®
11/06/2024 -
Monaghan Medical Corporation and Captis Continue to Partner to Improve Patient Outcomes
11/06/2024 -
GRI Bio (NASDAQ: GRI) to Present at the Virtual Investor Pitch Conference
11/06/2024 -
Longeveron® Announces Completion of Successful Investigator Meeting for On-going Phase 2b Clinical Trial Evaluating Lomecel-B™ as a Potential Treatment for HLHS, a Rare Pediatric Cardiac Disease
11/06/2024 -
CanaQuest Announces Key Appointments to Team to Drive CQ-001 through Clinical Trials
11/06/2024 -
IntelGenx Announces Initiation of the Sale and Investment Solicitation Process
11/06/2024 -
International Myeloma Foundation (IMF) to Honor 2024 Kyle and Durie Achievement Awardees, Dr. Shaji Kumar and Dr. Francesca Gay
11/06/2024 -
NurExone Announces Expansion of ExoPTEN Patent Coverage with Notice of Allowance for Japanese Patent Application
11/06/2024 -
NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America
11/06/2024 -
Sofwave Medical Receives Marketing Clearance in Canada for Pure Impact™ Strength and Muscle Toning Device
11/06/2024 -
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024
11/06/2024 -
SeaStar Medical’s Selective Cytopheretic Device Featured in Two Presentations at the 42nd Vicenza Course AKI-CRT-ECOS and Critical Care Nephrology
11/06/2024
Pages